Pacific Biosciences of California, Inc. PACB Income Statement

Pacific biosciences of california, inc. (PACB)

Income statement / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11
Revenue:
Revenue
15,598	27,930	21,915	24,621	16,425	19,526	18,160	21,578	19,362	24,935	23,545	20,073	24,915	25,722	25,118	20,747	19,127	36,281	13,917	24,939	17,645	16,904	20,623	11,425	11,642	9,134	7,421	6,048	5,578	5,878	2,776	7,291	10,038	12,444	10,519	10,630	270
Cost of revenue:
Cost of revenue
8,110	14,998	15,001	15,008	11,308	13,780	14,968	12,716	12,066	15,441	15,318	12,072	15,978	14,348	12,480	10,103	9,623	9,815	7,366	10,433	11,718	12,466	7,461	8,299	8,966	5,945	6,180	4,989	4,648	5,251	2,586	7,016	10,190	-	7,191	2,731	-
Gross profit
7,488	12,932	6,914	9,613	5,117	5,746	3,192	8,862	7,296	9,494	8,227	8,001	8,937	11,374	12,638	10,644	9,504	26,466	6,551	14,506	5,927	4,438	13,162	3,126	2,676	3,189	1,241	1,059	930	627	190	275	-152	1,537	3,328	7,899	270
Operating expense:
Research and development
15,250	14,273	14,962	14,910	15,485	16,263	14,356	15,664	16,311	15,626	15,844	16,883	16,971	16,255	17,479	17,522	16,361	14,752	16,162	15,043	14,483	12,331	11,693	12,435	11,771	11,133	10,419	11,682	11,983	11,652	12,626	11,272	12,073	12,415	20,001	19,546	24,118
Sales, general and administrative
24,947	16,576	20,066	19,083	19,766	20,106	13,506	14,943	14,934	14,397	13,952	15,505	15,265	12,993	11,894	11,192	11,708	12,776	10,818	10,821	10,772	10,001	9,882	8,993	9,150	9,060	10,757	9,374	9,554	10,669	10,143	11,558	15,285	11,811	12,764	11,016	11,119
Gain on lease amendments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	23,043	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total operating expense
40,197	30,849	35,028	33,993	35,251	36,369	27,862	30,607	31,245	30,023	29,796	32,388	32,236	29,248	29,373	28,714	28,069	27,528	3,937	25,864	25,255	22,332	21,575	21,428	20,921	20,193	21,176	21,056	21,537	22,321	22,769	22,830	27,358	24,226	32,765	30,562	35,237
Operating loss
-32,709	-17,917	-28,114	-24,380	-30,134	-30,623	-24,670	-21,745	-23,949	-20,529	-21,569	-24,387	-23,299	-17,874	-16,735	-18,070	-18,565	-1,062	2,614	-11,358	-19,328	-17,894	-8,413	-18,302	-18,245	-17,004	-19,935	-19,997	-20,607	-21,694	-22,579	-22,555	-27,510	-22,689	-29,437	-22,663	-34,967
Gain from Continuation Advances
34,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest expense
267	678	664	644	625	628	616	598	581	624	633	826	838	839	821	795	779	773	741	715	697	725	716	701	686	693	686	673	426	-	68	69	-	-	-	-	-
Other income, net
238	504	-345	428	435	452	242	-197	351	391	181	-326	270	-317	62	366	-8	426	-52	138	-148	-356	-34	-133	45	466	134	199	-71	162	-82	137	-70	153	156	188	158
Net income (loss)
1,262	-91	-29,123	-24,596	-30,324	-30,799	-25,044	-22,540	-24,179	-20,762	-22,021	-25,539	-23,867	-19,030	-17,494	-18,499	-19,352	-1,409	1,821	-11,935	-20,173	-18,975	-9,163	-19,136	-18,886	-17,231	-20,487	-20,471	-21,104	-21,669	-22,729	-22,487	-27,580	-22,823	-29,281	-22,475	-34,809
Other comprehensive income (loss):
Unrealized gain on investments
25	-6	-6	11	42	-12	-8	22	-6	-30	14	-13	-8	-18	-29	11	48	-13	-6	-4	7	-14	-19	24	4	3	13	-13	-19	-36	-9	-60	78	-	-	-	-
Comprehensive income (loss)
1,287	-97	-29,129	-24,585	-30,282	-30,811	-25,052	-22,518	-24,185	-20,792	-22,007	-25,552	-23,875	-19,048	-17,523	-18,488	-19,304	-1,422	1,815	-11,939	-20,166	-18,989	-9,182	-19,112	-18,882	-17,228	-20,474	-20,484	-21,123	-21,705	-22,738	-22,547	-27,502	-22,762	-29,466	-22,297	-34,785
Net income (loss) per share:
Basic and diluted net loss per share
-	-	-0.19	-0.16	-	-0.20	-0.19	-0.17	-0.20	-0.16	-0.19	-0.26	-0.26	-0.20	-0.19	-0.21	-0.23	-	-	-0.16	-0.27	-	-	-0.27	-0.28	-0.25	-0.31	-0.33	-0.37	-0.38	-0.41	-0.40	-0.50	-0.41	-0.54	-0.42	-0.66
Shares used in computing basic and diluted net loss per share
-	-	152,983	152,776	-	149,596	135,130	131,882	123,768	116,627	115,771	97,360	92,970	92,730	92,110	88,148	83,604	-	-	74,733	74,149	-	-	70	67,861	66,319	65,523	61,922	57,372	56,196	55,877	55,658	55,201	161,106	54,283	53	52
Basic
0.01	-	-	-	-0.20	-	-	-	-	-	-	-	-	-	-	-	-	-	0.02	-	-	-	-0.13	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Diluted
0.01	-	-	-	-0.20	-	-	-	-	-	-	-	-	-	-	-	-	-	0.02	-	-	-	-0.13	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Weighted average shares outstanding used in calculating net income (loss) per share
Basic
153,453	-	-	-	151,274	-	-	-	-	-	-	-	-	-	-	-	-	-	75,205	-	-	-	70,740	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Diluted
155,855	-	-	-	151,274	-	-	-	-	-	-	-	-	-	-	-	-	-	80,479	-	-	-	70,740	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Product [Member]
Revenue
12,293	24,551	18,484	21,250	13,457	16,438	15,150	18,485	16,282	21,845	20,343	16,548	21,294	20,593	18,050	13,587	12,379	9,799	7,570	8,825	11,308	12,923	6,762	7,749	7,865	5,791	5,814	4,601	3,833	4,279	1,268	5,827	8,715	-	9,819	10,148	-
Cost of revenue
5,421	11,985	12,188	11,980	8,618	10,926	12,250	9,858	9,019	11,836	11,547	8,155	11,362	11,244	9,273	7,115	6,880	7,415	5,119	8,438	9,732	10,578	5,608	6,271	7,169	4,568	4,616	3,322	3,200	3,847	960	5,382	8,607	-	6,546	2,537	-
Service and Other [Member]
Revenue
3,305	3,379	3,431	3,371	2,968	3,088	3,010	3,093	3,080	3,090	3,202	3,525	3,621	3,783	3,472	3,564	3,152	2,886	2,751	2,518	2,741	2,285	2,165	1,980	2,081	1,647	1,607	1,447	1,745	2,274	1,283	1,284	1,053	-	535	192	-
Cost of revenue
2,689	3,013	2,813	3,028	2,690	2,854	2,718	2,858	3,047	3,605	3,771	3,917	4,616	3,104	3,207	2,988	2,743	2,400	2,247	1,995	1,986	1,888	1,853	2,028	1,797	1,377	1,564	1,667	1,448	1,404	1,626	1,634	1,583	-	645	194	-
Contractual [Member]
Revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	1,346	3,596	3,596	3,596	23,596	3,596	13,596	3,596	1,696	11,696	1,696	1,696	-	-	-	-	-	225	180	270	-	165	290	270